Ignite Creation Date:
2025-12-25 @ 12:33 AM
Ignite Modification Date:
2026-02-24 @ 10:01 AM
Study NCT ID:
NCT03755167
Status:
SUSPENDED
Last Update Posted:
2025-01-10
First Post:
2018-11-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Follow up Study to Protocol 101/2 - Continued Treatment by IPL344 IV
Sponsor:
Immunity Pharma Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Amyotrophic Lateral Sclerosis (ALS) | View |
Keywords: